PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4310-4314

  Möller, Andreas ^a,b   Sirma, Hüseyin ^c   Hofmann, Thomas G ^c   Rueffer, Sven ^a   Klimczak, Elisabeth ^a   Dröge, Wulf ^a   Will, Hans ^c   Schmitz, M Lienhard ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HOMEODOMAIN PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; COILED BODY; CONTROLLED STUDY; ENZYME INACTIVATION; FIBROBLAST; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NUCLEAR DOMAIN 10; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY;

CARRIER PROTEINS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OSTEOSARCOMA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 2442678753     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dundr, M., and Misteli, T. Functional architecture in the cell nucleus. Biochem. J., 356: 297-310, 2001.
2. Tucker, K. E., Berciano, M. T., Jacobs, E. Y., LePage, D. F., Shpargel, K. B., Rossire, J. J., Chan, E. K., Lafarga, M., Conlon, R. A., and Matera, A. G. Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J. Cell Biol., 154: 293-307, 2001.
3. Shpargel, K. B., Ospina, J. K., Tucker, K. E., Matera, A. G., and Hebert, M. D. Control of Cajal body number is mediated by the coilin C-terminus. J. Cell Sci., 116: 303-312, 2003.
4. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., and Dejean, A. The PML-RAR α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66: 675-684, 1991.
5. Huang, M. E., Ye, Y. C., Chen, S. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu, L. J., and Wang, Z. Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72: 567-572, 1988.
6. Melnick, A., and Licht, J. D. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 93: 3167-3215, 1999.
7. Maul, G. G., Negorev, D., Bell, P., and Ishov, A. M. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol., 129: 278-287, 2000.
8. Eskiw, C. H., and Bazett-Jones, D. P. The promyelocytic leukemia nuclear body: sites of activity? Biochem. Cell Biol., 80: 301-310, 2002.
9. Salomoni, P., and Pandolfi, P. P. The role of PML in tumor suppression. Cell, 108: 165-170, 2002.
10. Kiesslich, A., von Mikecz, A., and Hemmerich, P. Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J. Struct. Biol., 140: 167-179, 2002.
11. Borden, K. L. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell Biol., 22: 5259-5269, 2002.
12. Sternsdorf, T., Guldner, H. H., Szostecki, C., Grotzinger, T., and Will, H. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol., 42: 257-268, 1995.
13. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., Piaggio, G., Fanciulli, M., Appella, E., and Soddu, S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol., 4: 11-19, 2002.
14. Hofmann, T. G., Möller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M. L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol., 4: 1-10, 2002.
15. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Sternsdorf, T., Jensen, K., Pandolfi, P. P., Will, H., Schneider, C., and Del Sal, G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J., 19: 6185-6195, 2000.
16. 2-terminal kinase activation. J. Exp. Med., 192: 1165-1174, 2000.
17. Huang, D. C., Adams, J. M., and Cory, S. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J., 17: 1029-1039, 1998.
18. Zirwes, R. F., Eilbracht, J., Kneissel, S., and Schmidt-Zachmann, M. S. A novel helicase-type protein in the nucleolus: protein NOH61. Mol. Biol. Cell, 11: 1153-1167, 2000.
19. Bischof, O., Kirsh, O., Pearson, M., Itahana, K., Pelicci, P. G., and Dejean, A. Deconstructing PML-induced premature senescence. EMBO J., 21: 3358-3369, 2002.
20. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., and Paolo, P. P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol., 2: 730-736, 2000.
21. Kim, Y. H., Choi, C. Y., and Kim. Y. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc. Natl. Acad. Sci. USA, 96: 12350-12355, 1999.
22. Zhong, S., Salomoni, P., and Pandolfi, P. P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol., 2: E85-E90, 2000.
23. Saito, S., Goodarzi, A. A., Higashimoto, Y., Noda, Y., Lees-Miller, S. P., Appella, E., and Anderson, C. W. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem., 277: 12491-12494, 2002.
24. Muratani, M. Gerlich, D., Janicki, S. M., Gebhard, M., Eils, R., and Spector, D. L. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol., 4: 106-110, 2002.
25. Fuchsova, B., Novak, P., Kafkova, J., and Hozak, P. Nuclear DNA helicase II is recruited to IFN-α-activated transcription sites at PML nuclear bodies. J. Cell Biol., 158: 463-473, 2002.
26. Engelhardt, O. G., Boutell, C., Orr, A., Ullrich, E., Haller, O., and Everett, R. D. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp. Cell Res., 283: 36-50, 2003.
27. Ecsedy, J. A., Michaelson, J. S., and Leder, P. Homeodomain-interacting protein kinase 1 modulates Daxx localization, phosphorylation, and transcriptional activity. Mol. Cell Biol., 23: 950-960, 2003.